Beta Bionics retweeted
“Diabetes doesn’t limit you in anyway. You can do absolutely anything with it.” 💪
The mission of @BetaBionics is simple, they’re a company dedicated to simplifying and improving the treatment of diabetes.
CEO Sean Saint shares the company story, his entrepreneurial journey, words of wisdom, and more. Check it out. 🎤🎥
Beta Bionics retweeted
⚡ 80% of people with diabetes live with uncontrolled blood glucose and are at risk from complications. @BetaBionics is working to change that.
🎉 We’re so excited $BBNX is now #NasdaqListed! Catch the recap of their big day. ⬇️
Beta Bionics retweeted
🗻 From a child’s diabetes diagnosis to becoming #NasdaqListed: what a journey for @BetaBionics!
🤝 Proud to be your exchange partner as you continue to make diabetes easier for everyone, every day.
Beta Bionics retweeted
.@BetaBionics $BBNX makes its IPO today, and CEO Sean Saint joined @OJRenick to give an overview of the company.
"The iLet Bionic Pancreas: the next generation of insulin pumps" ⬇️
Today is a significant day in Beta Bionic's history as we formally go public. Our message is lighting up Times Square today, and this milestone truly represents the dreams and hard work that led to this accomplishment.
$BBNX
Beta Bionics retweeted
🫶 Making diabetes easier for everyone, every day .
🤖 @BetaBionics is a medical technology company dedicated to simplifying and improving the treatment of diabetes.
🔔 Thrilled to ring in your @NasdaqExchange listing, $BBNX!
Beta Bionics retweeted
Congrats to @BetaBionics on their IPO today.
My 13-year-old son was diagnosed with #T1D 3 1/2 years ago.
Insulin pumps with CGM integration and automated insulin delivery change lives.
The T1D community applauds each technology advancement on the road to a cure. $BBNX
Announcing a game-changing integration with @AbbottNews and @FreeStyleDiabetes FreeStyle Libre 3 Plus sensor with our iLet Bionic Pancreas! 🎉
Discover if the iLet Bionic Pancreas is right for you by visiting the link in our bio.
*User must be carb aware.
Safety Link in bio
Great news for Android users! 🎉 The Beta Bionic Circle app is now live, letting loved ones easily stay connected to your diabetes management. Download now and join the circle! #GoBionic Learn how at: bit.ly/bionic_circle
Exciting news! iLet users can now invite friends and family to join their #BionicCircle to see their diabetes data and receive alerts. Learn how: betabionics.com/resources/bi…
We’re excited to announce that we’re partnering with @AbbottNews and @FreeStyleDiabet to integrate the FreeStyle Libre 3 Plus sensor with the iLet Bionic Pancreas.
Learn more: betabionics.com/beta-bionics…
We’re excited to announce that we’re partnering with @XerisPharma on the development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump.
newswire.com/news/xeris-ente…
We're proud to be featured on Fierce Medtech's latest Fierce 15 list, an annual report that recognizes the most innovative private medtech companies in the industry.
fiercebiotech.com/special-re…
The iLet Bionic Pancreas is now available nationwide with the Dexcom G7 CGM System.
No new hardware is needed, and the iLet is compatible with all versions of Dexcom G7. Learn more: betabionics.com/
This morning, we announced the nationwide launch of the iLet Bionic Pancreas with Dexcom G7 System planned for December 18, 2023.
Learn more: betabionics.com/ilet-bionic-…
Did you hear the news? @ExpressScripts has added the iLet Bionic Pancreas and associated monthly supplies to their commercial national formulary offerings.
betabionics.com/beta-bionics…
We are proud to be included in @TIME's Best Inventions of 2023 list! #TIMEBestInventions
We are thrilled to announce the successful closure of our Series D funding round securing $100 million in new equity capital.
newswire.com/news/beta-bioni…
Did you miss yesterday's Tuesday Talk featuring Beta Bionics Founder and Executive Chairman Ed Damiano? If so, good news! A recording is now available. Register below to watch.
linkedin.com/events/afatherw…
















